Dergiler / Solunum / 2012 / Cilt: 14 - Sayı: 2

Sexual function in obstructive sleep apnea syndrome

Obstrüktif uyku apne sendromunda seksüel fonksiyon

Dergi
Solunum
Sayfa
93–98
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

SB’si olan OUAS’li hastalarda SB’nin mekanizması ve SB’nin tedavisi için ek çalışmalara ihtiyaç vardır.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Amaç: Obstrüktif uyku apne sendromu (OUAS) sık görülen bir durumdur.
📊
Temel Bulgular & Veri:Gereç ve Yöntem: Çalışma popülasyonu 34 OUAS hastasından oluştu.
💡
Sonuç & Katkı:SB’si olan OUAS’li hastalarda SB’nin mekanizması ve SB’nin tedavisi için ek çalışmalara ihtiyaç vardır.
🔬Tür:Araştırma Makalesi
📍Kapsam:13 hasta
⚙️Değişkenler:Alan Parametreleri

Özet

Amaç: Obstrüktif uyku apne sendromu (OUAS) sık görülen bir durumdur. Sekelleri arasında sertleşme bozukluğu (SB) bulunur. Çalışmamızın amacı OUAS ile SB arasındaki ilişkiyi ortaya koymaktır. Gereç ve Yöntem: Çalışma popülasyonu 34 OUAS hastasından oluştu. Kontrol grubuna (basit horlama) 13 hasta alındı. Demografik özellikler, beden kitle indeksi (BKİ), polisomnografik parametreler, Epworth Uykululuk Skalası (EUS) değeri ve seksüel fonksiyon durumu kaydedildi. Tüm hastaların ürolojik muayeneleri yapıldı. Seksüel fonksiyonlarını değerlendirmek için erkeklere “The International Index of Erectile Function-5 (IIEF-5)”, kadınlara “Female Sexual Function Index (FSFI)” uygulandı. AHİ 0,05). Sonuç: OUAS'lı hastalarda seksüel fonksiyonlar etkilenmektedir. SB’si olan OUAS’li hastalarda SB’nin mekanizması ve SB’nin tedavisi için ek çalışmalara ihtiyaç vardır.

Abstract

Aim: Obstructive sleep apnea syndrome (OSAS) is a common medical problem. Among its sequelae, erectile dysfunction (ED) has been reported. The aim of this study aim was to clarify the association between OSAS and ED. Materials and Methods: The study population consisted of 34 OSAS patients and 13 control patients with simple snoring. Demographics, body mass index (BMI), polysomnography parameters, Epworth Sleepiness Scale (ESS) score, and sexual function situation were noted. All patients underwent urologic examination. The International Index of Erectile Function -5 (IIEF-5) was performed to males, and Female Sexual Function Index (FSFI) was performed to females in order to evaluated sexual functions. Patients were grouped as the control group whose apnea- hypopnea index was below 5, and as the study group with respiratory disturbance index RDI≥ 5. The data were statistically analyzed by using Kruskal Wallis Variance Analysis, Mann Whitney U Test with Bonferroni Correction, Independent Samples t Test and Mann Whitney U Test. Results: ED was found in 24 (70.6%) of 34 patients on the basis of their symptoms. Most of the patients with ED (40%) had severe OSAS. There was a statistically significant relation between Body Mass Index (BMI) and ED (p=0.007). We found ED in 24 patients according to the IIEF-5 score. There was a statistically significant difference in the minimum O2 saturation f.indings between the OSAS patients with and without ED (p=0.044). Respiratory Disturbance Index (RDI) and ESS were higher in the patients with severe ED in comparison to the patients without ED, but the difference wasn’t statistically significant (p>0.05). Conclusion: Sexual functions have been found to be affected in patients with OSAS. Additional studies are needed to ascertain the mechanism of ED in OSAS and the treatment of ED in this group of patients.

🔖

Bu Makaleye Atıf Yap

ÖZKUT, S., AKDAĞ, B., BOLAT, D., DURSUNOĞLU, N., ESKİÇORAPÇI, S., KARA, C. O. (2012). Sexual function in obstructive sleep apnea syndrome. Solunum, Cilt: 14 - Sayı: 2, 93–98. https://ajindex.com/articles/318466

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (17)

  1. Muers MF. The rational use of nebulizers in clinical practice. Eur Respir Rev 1997;7;189-197
  2. British Thoracic Society Nebulizer Project Group. Current best practice for nebuliser treatment. Thorax 1997;52(Suppl 2):S1-S3
  3. Muers MF. Overview of nebulizer treatment. Thorax 1997;52(Supp 2):25-30
  4. Sly PD, LeSouef PN. Inhaled therapy in paediatrics. J Paediatr Child Health 1991;27:7-10
  5. Guidelines prepared by a European Respiratory Society Task Force on the use of nebulizers: Boe J, Dennis JH, O'Driscoll BR, Bauer TT, Carone M, Dautzenberg B, et al. European Respiratory Society Guidelines on the use of nebulizers. Eur Respir J 2001;18:228-242
  6. Janssens HM, Tiddens HA. Aerosol therapy: the special needs of young children. Paediatr Respir Rev 2006;7:S83-S35
  7. Everard ML Aerosol delivery to children. Pediatr Ann 2006;35:630- 636
  8. Dolovich MA, MacIntyre NR, Anderson PJ, Camargo CA Jr, Chew N, Cole CH, et al. Consensus statement: aerosols and delivery devices. American Association for Respiratory Care 2000;45:589-596
  9. Rubin BK. Nebulizer therapy for children: the device-patient interface. Respir Care 2002;47:1314-1319
  10. Dolovich M. Device Selection and outcomes of aerosol therapy: evidence based quidelines. Chest 2005;127:335-371
  11. Chua HL, Collis GG, Newbury AM, Chan K, Bower GD, Sly PD, et al. The influence of age on aerosol deposition in children with cystic fibrosis. Eur Respir J 1994; 7:2185-2191
  12. Laube BL, Swift DL, Wagner HN Jr, Norman PS, Adams GK 3rd. The effect ofbronchial abstruction on central airways deposition of saline aerosol in patients with asthma. Am Rev Respir Dis 1986;133:740- 743
  13. Newman SP, Pavia D, Clarke SW. Improving the bronchial deposition of pressurized aerosols. Chest 1981;80(6 Suppl):909-911
  14. Laube BL. In vivo measurements of aerosol dose and distrubition: clinical relevance. J Aerosol Med 1996;9(Suppl 1):S77-S91
  15. Laube BL. The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination. Respiratory Care 2005;50:1162-1176
  16. Cantón R, Cobos N, de Gracia J, Baquero F, Honorato J, Gartner S, et al. Spanish Consensus Group for Antimicrobial Therapy in the Cystic Fibrosis Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Patient Clin Microbiol Infect 2005;11:690-703
  17. Frederiksen B, Lanng S, Koch C, Høiby N. Improved survival in the Danish center-treated cystic fibrosis patients: results